56 



Mr. DeNoble. We did. We were able to get that Friday to. Right, 

 we went back the next day on Friday and we did kill all our rats. 

 And at that point, the lab was over, it was ended. 



Mr. Mele. May I add something here? 



Mr. Waxman. Yes. Dr. Mele. 



Mr. Mele. Because I was going through this recently, we did — 

 that Friday was a critical day to end one study. I don't remember 

 what the study was, but it was a final manipulation of a long series 

 of manipulations. And we did ask for permission to, at least, finish 

 that study. And that was denied. 



Mr. Waxman. What do you mean, manipulations? 



Mr. Mele. It was a chronic dosing study, and this was the day 

 where the animals would have been tested to see how they re- 

 sponded. I don't remember, again, the details of the study, but we 

 did try and get that one final data point, and they didn't even want 

 us to continue that much. It wasn't of much interest to the com- 

 pany, it was of interest to us. 



Mr. Waxman. Did you ever go back to the lab? 



Mr. DeNoble. I had the occasion to go back to the lab a few days 

 later, the following week, because I had the combination to a safe 

 where we kept some controlled substances, yes. 



Mr. Waxman. And what did you find? 



Mr. DeNoble. The lab was gone, everything was gone. The 

 equipment was gone, the cages were gone, the animals were gone, 

 all the data was gone. It was empty rooms. 



Mr. Waxman. Was it as if there had never been a lab there be- 

 fore? 



Mr. DeNoble. You'd probably think there was, but there was no 

 evidence there was any behavioral lab there. The only thing that 

 was there was the safe. Everything was gone. It was just gone. 



Mr. Waxman. OK. Thank you. Mr. Bliley? 



Mr. Bliley. Dr. DeNoble, could you clarify one point for me? Ear- 

 lier you mentioned lawyers from Philip Morris being in your lab in 

 1983. Isn't it correct that they were in your lab to collect docu- 

 ments to be produced in a lawsuit, perhaps the Cipollone case? 



Mr. DeNoble. I believe that is correct, yes. 



Mr. Bliley. And, Mr. Chairman, could we keep the record open 

 so that we can submit some questions in writing to these two gen- 

 tlemen? 



Mr. Waxman. Without objection, we will keep the record open, 

 and members of the subcommittee may have additional questions 

 they'll want you to respond to in writing. For the record, we would 

 ask you to make those responses. 



Mr. Bliley. Thank you, Mr. Chairman, I have no further ques- 

 tions. 



Mr. Waxman. Thank you, Mr. Bliley. Mr. Synar? 



Mr. Synar. Thank you, Mr. Chairman. Doctor, let me move on 

 to this issue of your termination of employment. 



After the lab closed, what career options did Philip Morris give 

 you? 



Mr. DeNoble. There were three options that were offered to us. 

 One was to stay with the company, the second one was to receive 

 a cash pay-out, and the third was to continue us on the payroll 

 until we located new positions elsewhere. 



